Jean-Louis Vanoverschelde, Belgium 

Can Gollmann-Tepeköylü, Austria 

Dr. Martin Andreas

Dr. Marco Di Eusanio

What to know in 2020

Consequences of AVR on young Women

Keywords: minimally invasive; mitral valve repair; mitral valve replacement

One benefit of minimally invasive cardiac surgery compared with conventional sternotomy is faster recovery after surgery, which results in shorter lengths of stay in hospital for patients. However, there are concerns over longer operative times, complication rates and durability of repair. The use of minimally invasive techniques for mitral valve repair is increasing but it is not currently clear whether the benefits of this approach over conventional sternotomy outweigh the disadvantages.

This article presents the largest meta-analysis, to date, comparing early and late outcomes of mitral valve repair via minimally invasive surgery versus a conventional sternotomy approach. Sá et al. assessed a broad range of outcomes, including operative times, mortality, complications and hospital stay.

Download below to discover the latest findings in mitral valve repair.

Click here to access the full publication

Edwards, Edwards Lifesciences, the stylized E logo, are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.

© 2020 Edwards Lifesciences Corporation. All rights reserved.

Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com

Keywords: aortic root replacement; aortic stenosis; aortic valve replacement; Bentall; Valsalva graft

Although the majority of Bentall procedures have been performed with mechanical valves, the use of bioprosthetic valves is increasing. Modifications to the Bentall procedure may further enable the use of bioprosthetic valves: use of Valsalva pseudosinuses may reduce stress on the bioprosthetic leaflets and reduce the incidence of thromboembolism.

Chirichilli et al. routinely perform the Bentall procedure using the Valsalva graft with a Carpentier‑Edwards PERIMOUNT or PERIMOUNT Magna Ease valve. Here, they present the long‑term follow-up data assessing durability and valve-related complications.

Click on the link below to find out more about the performance of the PERIMOUNT valves combined with a modified Bentall procedure.  

Click here to access the full publication 

For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

Edwards devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Edwards, Edwards Lifesciences, the stylized E logo, Carpentier-Edwards, Magna, Magna Ease, PERI, PERIMOUNT and PERIMOUNT Magna are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.

© 2020 Edwards Lifesciences Corporation. All rights reserved.

Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com